Prot #LP0162-1334: Tralokinumab Monotherapy for Adolescent Subjects with Moderate-to-Severe Atopic Dermatitis ECZTRA 6 (ECZema TRAlokinumab trial no. 6)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/28/18 → 11/28/21

Funding

  • LEO Pharma Inc ((OE) Prot #LP0162-1334)